scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.M402367200 |
P698 | PubMed publication ID | 15123605 |
P50 | author | Philippe Froguel | Q3379857 |
Domenico Accili | Q60572357 | ||
Kohjiro Ueki | Q65013004 | ||
Takashi Kadowaki | Q109941901 | ||
Ryozo Nagai | Q117217184 | ||
P2093 | author name string | Kazuo Hara | |
Toshimasa Yamauchi | |||
Ryo Suzuki | |||
Masato Kasuga | |||
Yasuo Terauchi | |||
Kazuyuki Tobe | |||
Masaki Kobayashi | |||
Yusuke Ito | |||
Jun Nakae | |||
Atsushi Tsuchida | |||
Junji Kamon | |||
Sato Takekawa | |||
Yusuke Hada | |||
Naoto Kubota | |||
Toshiyuki Maki | |||
P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages | Q24290861 | ||
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 | ||
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis | Q24308699 | ||
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase | Q24309462 | ||
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression | Q24670887 | ||
Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B | Q24675116 | ||
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | Q28505765 | ||
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 | Q28511676 | ||
Disruption of adiponectin causes insulin resistance and neointimal formation | Q28589597 | ||
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 | ||
Chapter 4 Preparation of Isolated Rat Liver Cells | Q29616604 | ||
Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1 | Q29617416 | ||
Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance | Q33588931 | ||
Insights into insulin resistance and type 2 diabetes from knockout mouse models | Q34011039 | ||
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice | Q34118282 | ||
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). | Q34377772 | ||
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation | Q34416242 | ||
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis | Q38361016 | ||
Phosphorylation of serine 256 by protein kinase B disrupts transactivation by FKHR and mediates effects of insulin on insulin-like growth factor-binding protein-1 promoter activity through a conserved insulin response sequence | Q42472986 | ||
AdipoQ is a novel adipose-specific gene dysregulated in obesity | Q42813232 | ||
Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling | Q42991205 | ||
Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway | Q47960215 | ||
Phosphoenolpyruvate carboxykinase (GTP) gene transcription and hyperglycemia are regulated by glucocorticoids in genetically obese db/db transgenic mice. | Q51571825 | ||
P433 | issue | 29 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | preproinsulin | Q7240673 |
P304 | page(s) | 30817-30822 | |
P577 | publication date | 2004-04-29 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity | |
P478 | volume | 279 |
Q79451644 | A high-fat diet has a tissue-specific effect on adiponectin and related enzyme expression |
Q59075025 | A novel role of globular adiponectin in treatment with HFD/STZ induced T2DM combined with NAFLD rats |
Q51389391 | A polymorphism in the gene encoding AdipoR1 affects olfactory recognition. |
Q33289104 | A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis |
Q49601942 | Abnormal cannabidiol confers cardioprotection in diabetic rats independent of glycemic control |
Q38297202 | Acetaldehyde increases endogenous adiponectin and fibrogenesis in hepatic stellate cells but exogenous adiponectin inhibits fibrogenesis |
Q44346911 | Activation of κ-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice |
Q46489423 | AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue. |
Q38344499 | AdipoR2 is transcriptionally regulated by ER stress-inducible ATF3 in HepG2 human hepatocyte cells |
Q37326561 | Adipocytokines and liver disease |
Q56656927 | Adipokine update – neue Moleküle, neue Funktionen |
Q35686289 | Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome |
Q36756703 | Adipokines and incident type 2 diabetes in an Aboriginal Canadian [corrected] population: the Sandy Lake Health and Diabetes Project |
Q36972589 | Adipokines and insulin resistance |
Q37486025 | Adipokines as regulators of muscle metabolism and insulin sensitivity |
Q37544637 | Adipokines in liver diseases |
Q55619181 | Adiponectin Signaling Pathways in Liver Diseases. |
Q37801870 | Adiponectin action from head to toe. |
Q34779508 | Adiponectin and adiponectin receptor genes are coexpressed during zebrafish embryogenesis and regulated by food deprivation |
Q29619211 | Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome |
Q30358456 | Adiponectin and cardiovascular disease: state of the art? |
Q33396150 | Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study |
Q38465754 | Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity |
Q33869503 | Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis |
Q47291168 | Adiponectin concentration in plasma is associated with muscle fiber size in healthy middle-aged men. |
Q46662601 | Adiponectin concentration is associated with muscle insulin sensitivity, AMPK phosphorylation, and ceramide content in skeletal muscles of men but not women. |
Q38427655 | Adiponectin downregulation is associated with volume overload-induced myocyte dysfunction in rats |
Q37657502 | Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration |
Q36946738 | Adiponectin in severe preeclampsia. |
Q42471925 | Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes |
Q37311261 | Adiponectin multimers in maternal plasma. |
Q42815878 | Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation |
Q85991895 | Adiponectin receptor expression in gastric carcinoma: implications in tumor development and progression |
Q35708104 | Adiponectin receptor signalling in the brain |
Q39723084 | Adiponectin receptors are downregulated in human gastric cancer |
Q51474553 | Adiponectin receptors gene expression in lymphocytes of obese and anorexic patients. |
Q47348856 | Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. |
Q33577630 | Adiponectin resistance and vascular dysfunction in the hyperlipidemic state |
Q26745026 | Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure |
Q46202689 | Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats |
Q37338105 | Adiponectin treatment attenuates inflammatory response during early sepsis in obese mice. |
Q64945853 | Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease. |
Q35061908 | Adiponectin, a key adipokine in obesity related liver diseases |
Q44240418 | Adiponectin, type 2 diabetes and cardiovascular risk |
Q33995313 | Adiponectin--a key adipokine in the metabolic syndrome |
Q50957771 | Adiponectin-Resistance in Obesity. |
Q93048682 | Adiponectin/AdipoR Research and Its Implications for Lifestyle-Related Diseases |
Q33914270 | Adiponectin/adiponectin receptor in disease and aging |
Q37505809 | Adiponectin: a key adipokine in alcoholic fatty liver |
Q34549919 | Adiponectin: a link between obesity and cancer |
Q35763433 | Adiponectin: an adipokine with protective features against metabolic syndrome. |
Q38017897 | Adiponectin: mechanistic insights and clinical implications |
Q37262617 | Adipose tissue dysfunction in obesity, diabetes, and vascular diseases |
Q36080136 | Aerobic training increases the expression of adiponectin receptor genes in the peripheral blood mononuclear cells of young men. |
Q37338142 | Altered levels of adiponectin and adiponectin receptors may underlie the effect of ciliary neurotrophic factor (CNTF) to enhance insulin sensitivity in diet-induced obese mice |
Q28574928 | Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway |
Q46417040 | Association of ADIPOR2 with liver function tests in type 2 diabetic subjects |
Q35001834 | B-cell chronic lymphocytic leukemia risk in association with serum leptin and adiponectin: a case-control study in Greece |
Q80984953 | Brain neuropeptide Y and CCK and peripheral adipokine receptors: temporal response in obesity induced by palatable diet |
Q64231858 | BuShenKangShuai Tablet Alleviates Hepatic Steatosis via Improving Liver Adiponectin Resistance in ApoE Mice |
Q37089148 | CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications |
Q46577861 | Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy. |
Q35644252 | Chinese medicine Jinlida (JLD) ameliorates high-fat-diet induced insulin resistance in rats by reducing lipid accumulation in skeletal muscle. |
Q36983863 | Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise |
Q33363300 | Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis. |
Q28570944 | Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats |
Q42288208 | Cross Talk between Adipose Tissue and Placenta in Obese and Gestational Diabetes Mellitus Pregnancies via Exosomes |
Q93016060 | Cytochrome P450 endoplasmic reticulum-associated degradation (ERAD): therapeutic and pathophysiological implications |
Q37710228 | Diabetes mellitus, inflammation, obesity: proposed treatment pathways for current and future therapies |
Q43554666 | Difference in the ratio of high-molecular weight (HMW) to total adiponectin and HMW adiponectin in late post-menopausal women |
Q34615504 | Differential expression of novel adiponectin receptor-1 transcripts in skeletal muscle of subjects with normal glucose tolerance and type 2 diabetes |
Q79393990 | Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals |
Q46178402 | Disturbed adiponectin – AMPK system in skeletal muscle of patients with metabolic syndrome. |
Q90646902 | Does Epicardial Adipose Tissue Influence Postoperative Atrial Fibrillation? |
Q44331224 | Early lesion formation in colorectal carcinogenesis is associated with adiponectin status whereas neoplastic lesions are associated with diet and sex in C57BL/6J mice |
Q35598833 | Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia |
Q33751618 | Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance |
Q34695462 | Effect of adiponectin on kidney crystal formation in metabolic syndrome model mice via inhibition of inflammation and apoptosis |
Q47254809 | Effect of berberine on the ratio of high-molecular weight adiponectin to total adiponectin and adiponectin receptors expressions in high-fat diet fed rats |
Q42062446 | Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats |
Q54397507 | Effect of telmisartan on the expression of cardiac adiponectin and its receptor 1 in type 2 diabetic rats. |
Q40142825 | Effects of Low-Dose Developmental Bisphenol A Exposure on Metabolic Parameters and Gene Expression in Male and Female Fischer 344 Rat Offspring |
Q46740958 | Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats. |
Q28568897 | Effects of high levels of glucose on the steroidogenesis and the expression of adiponectin receptors in rat ovarian cells |
Q46575092 | Effects of icodextrin on insulin resistance and adipocytokine profiles in patients on peritoneal dialysis |
Q53561556 | Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet. |
Q59798152 | Electroacupuncture Mitigates Skeletal Muscular Lipid Metabolism Disorder Related to High-Fat-Diet Induced Insulin Resistance through the AMPK/ACC Signaling Pathway |
Q37338559 | Endocrine functions of adipose tissue: focus on adiponectin |
Q58773071 | Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats |
Q40120793 | Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver |
Q92537528 | Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases |
Q39294192 | Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma |
Q35753110 | Expression of Adiponectin Receptors on Peripheral Blood Leukocytes of Hypertensive Children Is Associated with the Severity of Hypertension |
Q36716485 | Expression of adiponectin receptors 1 (AdipoR1) and 2 (AdipoR2) in the porcine pituitary during the oestrous cycle. |
Q92183551 | Expression of adiponectin receptors in the brain of adult zebrafish and mouse: Links with neurogenic niches and brain repair |
Q34173809 | FOXO1: a potential target for human diseases |
Q27489896 | Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis |
Q45366869 | Fibrosis is associated with adiponectin resistance in chronic hepatitis C virus infection |
Q38162721 | FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis |
Q37855653 | Functional adiponectin resistance and exercise intolerance in heart failure. |
Q46732827 | Gene expression of adiponectin and adiponectin receptor 1 in type 2 diabetic rats and the relationship with the parameters of glucose and lipid metabolism |
Q37319777 | Gene expression of adiponectin receptors in human visceral and subcutaneous adipose tissue is related to insulin resistance and metabolic parameters and is altered in response to physical training |
Q33354965 | Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes |
Q42170113 | Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats |
Q41980049 | Guava leaf extracts alleviate fatty liver via expression of adiponectin receptors in SHRSP.Z-Leprfa/Izm rats |
Q46455710 | Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice |
Q53775867 | Hepatic adiponectin receptors (ADIPOR) 1 and 2 mRNA and their relation to insulin resistance in obese humans. |
Q57467670 | High Fat/High Glucose Diet Induces Metabolic Syndrome in an Experimental Rat Model |
Q41940630 | High protein/fish oil diet prevents hepatic steatosis in NONcNZO10 mice; association with diet/genetics-regulated micro-RNAs |
Q41843312 | High-fat diet and glucocorticoid treatment cause hyperglycemia associated with adiponectin receptor alterations |
Q37086463 | Hydrodynamic delivery of adiponectin and adiponectin receptor 2 gene blocks high-fat diet-induced obesity and insulin resistance |
Q33482846 | Hypothalamic neuroendocrine circuitry is programmed by maternal obesity: interaction with postnatal nutritional environment |
Q28291038 | Identification of adiponectin receptor agonist utilizing a fluorescence polarization based high throughput assay |
Q38640616 | Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects. |
Q88450624 | Identification, characterization, and expression analysis of adiponectin receptors in black carp Mylopharyngodon piceus in response to dietary carbohydrate |
Q53492192 | Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance. |
Q36202964 | Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis |
Q82988546 | Increase of adiponectin receptor gene expression by physical exercise in soleus muscle of obese Zucker rats |
Q35091596 | Increased abundance of the adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and leucine zipper motif (APPL1) in patients with obesity and type 2 diabetes: evidence for altered adiponectin signalling |
Q37662940 | Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis |
Q33237890 | Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies |
Q51548475 | Infliximab therapy restores adiponectin expression in perivascular adipose tissue and improves endothelial nitric oxide-mediated vasodilation in mice with type 1 diabetes. |
Q34334204 | Influence of exercise on the metabolic profile caused by 28 days of bed rest with energy deficit and amino acid supplementation in healthy men |
Q38335161 | Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. |
Q33942381 | Inherent insulin sensitivity is a major determinant of multimeric adiponectin responsiveness to short-term weight loss in extreme obesity |
Q64276655 | Insulin and Insulin Receptors in Adipose Tissue Development |
Q37417134 | Insulin resistance and other metabolic risk factors in the pathogenesis of hepatocellular carcinoma |
Q39264311 | Insulin-regulated expression of adiponectin receptors in muscle and fat cells |
Q54563354 | Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle. |
Q41864876 | Intensity of resistance exercise determines adipokine and resting energy expenditure responses in overweight elderly individuals |
Q37788976 | Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis. |
Q37390991 | Interactions of exercise training and high-fat diet on adiponectin forms and muscle receptors in mice |
Q37222183 | Kupffer cells in non-alcoholic fatty liver disease: the emerging view. |
Q46493226 | Lack of adiponectin and adiponectin receptor 1 contributes to benign prostatic hyperplasia |
Q36304715 | Lipopolysaccharide induces a downregulation of adiponectin receptors in-vitro and in-vivo |
Q50930149 | Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet. |
Q38315377 | MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness. |
Q42282446 | Maternal intake of grape seed procyanidins during lactation induces insulin resistance and an adiponectin resistance-like phenotype in rat offspring |
Q36675226 | Maternal serum adiponectin multimers in patients with a small-for-gestational-age newborn |
Q64059484 | Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease |
Q36304141 | Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease |
Q97532399 | Metabolic Messengers: Adiponectin |
Q36062224 | Metabolic syndrome and endothelial dysfunction |
Q26314465 | Molecular characterization of an adiponectin receptor homolog in the white leg shrimp, Litopenaeus vannamei |
Q37578545 | Molecular mechanisms involved in obesity-associated insulin resistance: therapeutical approach. |
Q46727558 | Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1. |
Q28476775 | N-acetylcysteine and allopurinol synergistically enhance cardiac adiponectin content and reduce myocardial reperfusion injury in diabetic rats |
Q39940439 | Negative regulation of adiponectin receptor 1 promoter by insulin via a repressive nuclear inhibitory protein element |
Q37054351 | Non-alcoholic fatty liver disease and the metabolic syndrome: an update |
Q37750871 | Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. |
Q50957755 | Obesity-associated Breast Cancer: Analysis of risk factors. |
Q30243992 | Obesity: Current and potential pharmacotherapeutics and targets |
Q43505530 | Orange-spotted grouper (Epinephelus coioides) adiponectin receptors: molecular characterization, mRNA expression, and subcellular location |
Q26766485 | Pancreatic regulation of glucose homeostasis |
Q58327102 | Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology |
Q80558968 | Pattern of expression of adiponectin receptors in human adipose tissue depots and its relation to the metabolic state |
Q47806979 | Pepsin egg white hydrolysate ameliorates metabolic syndrome in high-fat/high-dextrose fed rats |
Q34761266 | Peptides from adipose tissue in mental disorders |
Q36404495 | Physiological and pathophysiological regulation of regional adipose tissue in the development of insulin resistance and type 2 diabetes |
Q37366361 | Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases |
Q21246035 | Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults |
Q42484914 | Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. |
Q64255446 | Pulmonary Hypertension and Obesity: Focus on Adiponectin |
Q92723887 | Recent Data on Cellular Component Turnover: Focus on Adaptations to Physical Exercise |
Q40293523 | Regulation of adiponectin receptors in hepatocytes by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone |
Q54411028 | Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model |
Q34684171 | Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians |
Q35566570 | Relationships among Body Condition, Insulin Resistance and Subcutaneous Adipose Tissue Gene Expression during the Grazing Season in Mares |
Q36956120 | Resveratrol alleviates alcoholic fatty liver in mice |
Q36994616 | Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy |
Q35055513 | Role of SIRT1-FoxO1 signaling in dietary saturated fat-dependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice |
Q47960274 | Role of adiponectin and its receptor in prediction of reproductive outcome of metformin treatment in patients with polycystic ovarian syndrome |
Q37163429 | Role of adiponectin in human skeletal muscle bioenergetics |
Q38136560 | Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases |
Q38267491 | Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk |
Q34765518 | Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients |
Q38261195 | Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome. |
Q43016757 | Skeletal muscle inflammation is not responsible for the rapid impairment in adiponectin response with high-fat feeding in rats |
Q27024843 | Specific dietary patterns and concentrations of adiponectin |
Q41828178 | Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes |
Q35546840 | Strength training improves muscle quality and insulin sensitivity in Hispanic older adults with type 2 diabetes |
Q34365487 | Study of adiponectin in chronic liver disease and cholestasis |
Q52765994 | Suksdorfin Promotes Adipocyte Differentiation and Improves Abnormalities in Glucose Metabolism via PPARγ Activation. |
Q37798716 | Systemic effects of white adipose tissue dysregulation and obesity-related inflammation |
Q57249776 | Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions |
Q37610497 | Targeting tissue-specific metabolic signaling pathways in aging: the promise and limitations |
Q50058863 | The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes |
Q37677914 | The Fox genes in the liver: from organogenesis to functional integration |
Q42175159 | The Relationship between Preheparin Lipoprotein Lipase and Metabolic Derangements in Obese Japanese Children |
Q42707470 | The effect of resveratrol on the expression of AdipoR1 in kidneys of diabetic nephropathy |
Q34573323 | The myocyte expression of adiponectin receptors and PPARδ is highly coordinated and reflects lipid metabolism of the human donors |
Q37022175 | The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. |
Q34768157 | The role of FoxO in the regulation of metabolism. |
Q34271986 | The role of adiponectin in cancer: a review of current evidence |
Q38135763 | The role of adiponectin signaling in metabolic syndrome and cancer |
Q36161243 | Therapeutic perspectives of adipocytokines |
Q36602626 | Transcriptional regulation by insulin: from the receptor to the gene. |
Q28507112 | Transcriptomic and network component analysis of glycerol kinase in skeletal muscle using a mouse model of glycerol kinase deficiency |
Q53162775 | Tumor necrosis factor-α impairs adiponectin signalling, mitochondrial biogenesis, and myogenesis in primary human myotubes cultures. |
Q28566924 | Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect? |
Q38954621 | Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease |
Q49960522 | Variations in ADIPOR1 But Not ADIPOR2 are Associated With Hypertriglyceridemia and Diabetes in an Admixed Latin American Population. |
Q39979703 | Weight Gain Alters Adiponectin Receptor 1 Expression on Adipose Tissue-Resident Helios+ Regulatory T Cells |
Search more.